Abstract
The neuromuscular junction (NMJ) is a chemical synapse formed between a presynaptic motor neuron and a postsynaptic muscle cell. NMJs in most vertebrate species share many essential features; however, some differences distinguish human NMJs from others. This review will describe the pre- and postsynaptic structures of human NMJs and compare them to NMJs of laboratory animals. We will focus on age-dependent declines in function and changes in the structure of human NMJs. Furthermore, we will describe insights into the aging process revealed from mouse models of accelerated aging. In addition, we will compare aging phenotypes to other human pathologies that cause impairments of pre- and postsynaptic structures at NMJs. Finally, we will discuss potential intervention approaches for attenuating age-related NMJ dysfunction and sarcopenia in humans.
Highlights
Synapses are required to maintain the proper function of the nervous system both in health and during disease
The macromolecules in the active zones interact with docked synaptic vesicles, which has been revealed in frog and mouse neuromuscular junction (NMJ) by electron microscopy tomography (Harlow et al, 2001; Nagwaney et al, 2009; Szule et al, 2012; Harlow et al, 2013; Jung et al, 2018)
The acetylcholine receptors (AChR) of human NMJs have only been investigated at confocal-level resolution and has not yet been analyzed using super-resolution microscopy (Jones et al, 2017)
Summary
The neuromuscular junction (NMJ) is a chemical synapse formed between a presynaptic motor neuron and a postsynaptic muscle cell. NMJs in most vertebrate species share many essential features; some differences distinguish human NMJs from others. This review will describe the pre- and postsynaptic structures of human NMJs and compare them to NMJs of laboratory animals. We will focus on age-dependent declines in function and changes in the structure of human NMJs. we will describe insights into the aging process revealed from mouse models of accelerated aging. We will compare aging phenotypes to other human pathologies that cause impairments of pre- and postsynaptic structures at NMJs. we will discuss potential intervention approaches for attenuating age-related NMJ dysfunction and sarcopenia in humans
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
